• AIM: To test for the association between genome-wide methylation and myopia in human and mice.
INTRODUCTION
M yopia is a common eye disease worldwide. The prevalence of myopia varies widely among ethnic groups [1] [2] [3] [4] [5] .
Both genetic and environmental factors are important for the development of myopia [6] . Genetic association studies as well as gene expression studies have reported several susceptibility genes to myopia [7] [8] [9] . Recent Meta-analysis based on genome-wide association studies further identified several newly identified genetic loci [10] [11] [12] . On the other hand, several environmental risk factors were reported to be associated with myopia. Exposure to nearwork and nearwork related parameters such as continuous reading, reading distance, were environmental risk factors for myopia [13] . Outdoor activity is even demonstrated to be a protective factor against myopia Genome-wide DNA hypermethylation increase myopia risk Int J Ophthalmol, Vol. 12, No. 1, Jan. 18, 2019 www.ijo.cn Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com onset and progression in school children [14] [15] [16] [17] . Data from Metaanalysis also support the possibility of gene X environment interaction as a risk factor for myopia [18] . DNA methylation is a major type of epigenetic regulations, and in general DNA methylation silences gene expression. In adult non-gamete cells, DNA methylation normally occurs at multiple CpG sites in the CpG islands. DNA methylation can be assessed in a global way or gene-specific way. At a global level, the degree of DNA methylation can be measured by utilizing repeat interspersed regions such as long interspersed nucleotide element 1 (LINE-1) [19] because LINE-1 repeats hold approximately 17% of the human genome in size [20] . Several studies measured the LINE-1 methylation levels in leukocyte DNA to test for the association between global methylation and the risk of complex diseases [21] [22] [23] [24] . A change of DNA methylation level may result from an interaction between genetic and environmental factors. A global DNA methylation level has been proposed to be influenced by a number of endogenous and environmental factors [25] , such as tobacco smoke, air pollution, bisphenol A, and nutrient supplements [26] [27] . A major source of methyl donor for DNA methylation originates from homocysteine metabolism, and patients with homocystinuria also have high myopia [28] [29] . Homocysteine is biosynthesized from methionine via a multi-step process, and homocysteine can be also recycled into methionine. Previous studies have indicated that administration of homocysteine for a long period time could impair the dopaminergic system [30] . It needs to be noted that intravitreal application of dopamine agonist can suppress the development of myopia in animal studies [31] . Therefore, LINE-1 methylation, homocysteine and dopamine may have a complicated relationship that eventually affects a risk for myopia. The present study first tested for the association between global LINE-1 methylation level in leukocytes and high myopia in human subjects. We then conducted an animal study to test whether LINE-1 methylation level in leukocytes can reflect LINE-1 status in the ocular tissue. The association between LINE-1 methylation level and myopia was assessed in animals to validate the human study. Homocysteine and methionine were detected in rodent normal and myopic eyes. Finally, cellular studies were conducted to delineate the network connection among dopamine LINE-1 methylation and DNA methyltransferase-1 (DNMT1).
SUBJECTS AND METHODS Ethical Approval
Each subject signed a written informed consent. The study was approved by the Institutional Review Board at the Kaohsiung Medical University Hospital, Taiwan (KMUH-IRB-960238). The research followed the tenets of the Declaration of Helsinki. The refractive error was measured without cycloplegia using autorefractometers (Topcon KR-8100 or RM-8800; Topcon, Tokyo, Japan) for all eyes. Based on the data from our previous study of LINE-1 methylation [24] , 208 cases and 208 controls would provide a power of 80% with the type I error rate of 0.05. Pyrosequencing for LINE-1 DNA was isolated by Gentra (Qiagen, Hilden, Germany), according to the manufacturer's recommendations and stored at -20℃ until used in the subsequent steps. Sodium bisulfate was used to treat DNA samples to convert unmethylated cytosine to uracil, and to leave methylated cytosine intact. An EpiTect Fast Bisulfite Kit (Qiagen) was used for the above mentioned procedure. The completion of bisulfite treatment was evaluated by detecting unconverted bisulfite cytosine outside the CpG assuming that non-CpG cytosines were mainly unmethylated. The biotinylated polymerase chain reaction (PCR) products were purified and pyrosequencing was run on a PyroMark Q24 (Qiagen). Non-CpG cytosine residues were used as internal controls to validate the efficiency of sodium bisulfite DNA conversion. Universal unmethylated and methylated DNAs were run as controls. Methylation quantification was performed using the PyroMark Q24 2.0.6 software (Qiagen). The methylation level was calculated as percentage for methylated cytosine over the sum of methylated and unmethylated cytosine.
Induction of Form Deprivation Myopia in Mice
The study used C57BL/6J male specific pathogen free mice. These animals were purchased from the National Laboratory Animal Center (Taipei, Taiwan). Mice were maintained in a temperature-controlled (25℃) facility with a strict 12-h light: dark cycle. All animals were provided free access to food and water throughout the experiment. A total of 17 mice (23 days old) were used in this study, among which 6 mice were randomly selected to receive the form deprivation myopia (FDM) and 11 mice were used as normal controls (i.e. free of form deprivation). The right eyes of animals in the FDM group were covered on day 23 for four weeks to induce myopia, while the left eyes were uncovered as previous described [9] . After four weeks, the covers were removed and animals were sacrificed by isoflurane to extract DNA from the blood, retinal and scleral tissues in the laboratory. For FDM mice, only the covered eyes were used for the subsequent experiments.
Immunohistochemical Staining for Homocysteine and Methionine Two mice in the FDM group and 2 mice in the control group were randomly selected for the immunocytochemistry study. The eye sections were rinsed twice in PBS and then stained using specific antibodies. The two primary antibodies were mouse anti-methionine (AB6456; 1:100 for immunocytochemistry; Abcam, Cambridge, UK) and mouse anti-homocysteine (AB15154; 1:100 for immunocytochemistry; Abcam). These two antibodies were further detected by 0.05% diaminobenzidine (DAB, Vector Laboratories, Burlingame, CA, USA) and 0.03% H 2 O 2 . The immunohistochemical (IHC) stained sections were detected by a bright-field microscopy (Leica, Wetzlar, Germany).
Dopamine Treatment to Retinal Pigment Epithelial Cells
We purchased the human retinal pigment epithelial (RPE; ARPE-19) cell line from Bioresource Collection and Research Center (BCRC; Hsinchu, Taiwan) which derived from American Type Culture Collection (ATCC, Manassas, VA; ATCC number: CRL-2302). The cells were cultured in Dulbecco's modified Eagle's medium (Gibco-BRL, Gaithersburg, MD, USA) supplemented with 2 mmol/L l-glutamine (Sigma-Aldrich, St. Louis, MO, USA), 10% bovine fetal serum (Gibco-BRL), and 1 mmol/L pyruvate (Sigma-Aldrich). The cells were maintained at 37℃ in an atmosphere of 5% CO 2 . Dopamine (Sigma-Aldrich) was prepared in the final concentration of 10 μmol/L to treat the RPE cells for 24h. The analysis was conducted within five passages of the cells used in the experiments. RNA Isolation and Quantitative Real-time PCR for DNMT1 Total RNA was extracted using Trizol according to the manufacturer's instructions and the purity of RNA was checked using A260/A280 readings. cDNA was synthesized from 1 μg total RNA using random primers and the MultiScribe Reverse Transcriptase Kit (Applied Biosystems, Carlsbad, CA, USA). The cDNA was diluted 1:30 with PCR grade water and then stored at -20℃. For quantitative real-time PCR, specific primers were designed (DNMT1-F: 5'-AGG CGG CTC AAA GA TTT GGA A-3', DNMT1-R: 5'-GCA GAA ATT CGT GCA AGA GAT TC-3', GAPDH-F: 5'-GTG AAG GTC GGA GTC AAC-3', GAPDH-R: 5'-GTT GAG GTC AAT GAA GGG-3'). RNA levels were measured in the ABI 7500 real-time PCR machine (Applied Biosystems) with the pre-optimized condition. Each real-time PCR was performed in triplicate using 1 μL cDNA, 0.2 μL primer sets, 5 μL 2×SYBR Green PCR Master Mix, and 3.6 μL nucleotide-free H 2 O to yield a 10 μL reaction. The expression level of DNMT1 was normalized to that of GAPDH as the internal control. Statistical Analysis We used the Student's t test and Chisquare test to analyze the numeric and categorized variables, respectively. We equally divided the total participants into three groups (i.e. tertile) for a post-hoc analysis. Multivariate logistic regression model was used to determine the odds ratio (OR) of each quartile with adjustment for risk factors. The nonparametric Spearman rank correlation was calculated for LINE-1 methylation levels between leukocyte DNA and ocular DNA in the 11 mice. The non-parametric Mann-Whitney test was used to compare LINE-1 methylation levels in animal tissues. A two-sided P value less than 0.05 was considered statistically significant. All statistical calculations were performed by the JMP software (version 9). The statistical power was calculated by G*Power version 3.1.
RESULTS

DNA Methylation in Human Subjects
Based on the DNA availability and quality, 220 highly myopic cases and 220 sex-and age-matched controls were used for this study. The demographic data and LINE-1 methylation levels of study subjects are shown in Table 1 . The mean refraction error and standard error of mean (SEM) were -8.81±0.14 D for myopic subjects and -0.53±0.04 D for control subjects. The myopic subjects had a higher percentage for a college or higher education level than controls, while sex and age had no significant difference between the cases and controls ( Table 1) . The LINE-1 methylation level was significantly higher in the myopic subjects than controls (P=0.003, tissues, including retina and sclera. In our animal model, the rodent LINE-1 methylation level in the peripheral blood was significantly correlated with that in the ocular tissue in 11 normal mice (Figure 1) . The correlation coefficients of methylation levels were 0.63 (P=0.038) between the retina and leukocyte, and 0.68 (P=0.020) between the sclera and leukocyte. Furthermore, LINE-1 methylation levels in leukocyte, sclera and retina were significantly higher in the FDM mice than normal mice with a P value of 0.027, 0.018 and 0.032, respectively (Figure 2 ). The statistic power was greater than 0.80. Such data not only confirm the association between LINE-1 methylation level and myopia, but also justify the use of leukocyte DNA to surrogate ocular DNA for methylation studies in myopia.
Immunohistochemical Staining for Homocysteine and Methionine
Because homocysteine metabolism provides the methyl donor for DNA methylation, we then examined homocysteine and methionine expression in the mouse eyes. Four mice (two from the FDM group and two from the control group) that were originally used for methylation study were randomly selected for the IHC staining. The representative images are shown in Figure 3 . The results showed that the retina of FDM had increased staining of homocysteine and methionine than the retina from the normal mice. There was no observable difference of IHC staining for either homocysteine or methionine in the sclera between FDM and normal eyes ( Figure 3) . The above animal study suggested that FDM eyes had a higher homocysteine metabolism, which is consistent with human data [28] [29] . Dopamine Reduced LINE-1 Methylation Level There is no consensus on which cell type is the best for in vitro myopia studies. Because the above IHC data showed increased homocysteine in the retina, we decided to use a convenient human RPE cell to conduct the subsequent cell study. Dopamine has been repeatedly reported to effectively reduce myopia development in experimental animals [31] . To explore whether dopamine affects methylation process, we measured LINE-1 methylation and DNMT1 levels in the dopaminetreated RPE cells. Because DNMT1 is the most abundant DNA methyltransferase in mammalian cells, it is likely to be the key maintenance methyltransferase in mammals. After the 24h dopamine treatment, both LINE-1 methylation level and DNMT1 RNA level were significantly reduced (P=0.030 and 0.001, respectively) in the RPE cells (Figure 4 ). DISCUSSION Our study demonstrated that elevated global DNA methylation levels of LINE-1 in the leukocytes were independently associated with high myopia in human subjects. In the mouse study, we showed that the LINE-1 methylation levels in leukocytes and ocular tissue were significantly correlated. This result suggests peripheral blood may surrogate the ocular tissue in terms of LINE-1 methylation status. Our further animal experiment revealed that DNA isolated from rodent leukocyte, retina and sclera had higher LINE-1 methylation levels in the myopic mice. Therefore, the animal studies justify the validity of measuring LINE-1 status in peripheral leukocytes and confirm the result of human study. The concentrations of two amino acids (methionine and homocysteine) involved in the methylation process were higher in myopic eyes than normal eyes. Such data suggest excessive methyl donor in myopic eye leading to LINE-1 hypermethylation. Our study also first ever demonstrated that dopamine can decrease DNMT1, which in turn reduces LINE-1 methylation level. The present study provides an epigenetic mechanism for dopamine therapy in experimental myopia. Our finding and possible molecular mechanism is schematically depicted in Figure 5 . Homocysteine can be methylated and then be converted to methionine ( Figure 5 ). Methionine is an essential amino acid and can be activated to S-adenosylmethionine (SAM) that is a methyl donor for several metabolic reactions including DNA methylation. After losing its methyl group for DNA methylation, SAM is converted to S-adenosylhomocysteine (SAH) that can be further metabolized to homocysteine. Then, methionine can be regenerated from homocysteine. Myopic subjects have been reported to have high levels of circulating methionine [32] . Furthermore, homocystinuria is characterized by the presence of severe myopia [29, 33] , which implies accumulated homocysteine is a risk factor for myopia. Excessive methionine and homocysteine suggest a plenty of methyl group for LINE-1 DNA methylation, which may contribute to myopia development. In addition, a positive correlation between circulating methionine and leukocyte LINE-1 methylation was also found in colorectal cancer patients [34] . Dopamine plays an important role in the vertebrate visual system, and a reduction of retinal dopamine results in decreased visual contrast sensitivity [35] . Injection of dopamine agonists to the eyes can inhibit FDM development in animal models while injection of dopamine antagonists can enhance FDM development [31] . In addition, dopamine antagonist impairs the effect of bright light on myopia prevention [36] . Here we demonstrated that dopamine could reduce DNMT1 that is an enzyme for DNA methylation. Consistently, we found that dopamine could lower the LINE-1 methylation level. These findings may provide another mechanism to explain the dopamine effect on inhibiting myopia development. Aberrant DNA methylation has been implied in several complex diseases [37] [38] [39] [40] . Gene-environment interaction has long been considered a risk for myopia, but the molecule evidence to support this speculation is relatively sparse. Although DNA methylation can be a marker to test for gene-environment interaction, only few related studies in the context of myopia have been reported. Recently, Zhou et al [41] demonstrated that COL1A1 expression is modulated by DNA methylation during experimental myopia in mice. In their study, the methylation level in the COL1A1 promoter increased in the sclera of FDM eyes, but the level remained low in the fellow eye. Consequently, the FDM eyes had lower COL1A1 expression levels than the fellow and normal eyes. Discovery of the involvement of DNA methylation in myopia development not only provides more insight to emmotropization but also implies a potential opportunity for myopia intervention.
The study design has strengths and limitations. The study population was relatively homogenous in respect to age, ethnicity and geographic location. There may be a concern of misclassification of our control subjects if their refraction still progresses. However, it is well known that refraction progression slows down with age and mild myopia is unlikely to progress after age of 18 [42] [43] . Even though few control subjects had myopia progression to make them illegible as controls, our results should remain significant given that the original data had a P value of 0.003. However, the cross-sectional association study cannot test for the causal relationship. Therefore, we used the animal study to offer another line of evidence for LINE-1 hypermethylation as a risk for myopia. Another limitation is that the present study does not explain the exact role of LINE-1 in the myopia development. Since LINE-1 biological role has not been extensively studied, our results should be used as evidence to support the role of DNA methylation in myopia development. Further studies to disclose aberrant DNA methylation in specific genes are warranted to gain more understanding in myopia pathogenesis. Another concern is the measure of refraction without cycloplegia. A previous study using the subjects of similar age (aged 22 to 39y) reported that refraction measured without cycloplegia can be over-estimated by -0.23 D in myopes (defined as -1 D or less) and -0.43 D for emmetropes (defined as between -1 D to +1 D) [44] . Another study (aged 18 to 34y) reported that refraction without cycloplegia caused a more myopic estimate by -0.86 D regardless of the myopic or emmetropic participants [45] . However, both studies showed that the over-estimation is smaller for myopes than emmetropes. Since the mean of refraction is -8.81 D for myopic subjects and -0.53 D for our controls, the non-cycloplegia effect would not change their disease status and would not affect the results and conclusion.
In conclusion, the present study demonstrates that the methylation level in leukocyte LINE-1 is associated with myopia in both human and mice. Rodent LINE-1 methylation levels measured in blood and ocular tissue are significantly correlated, which justifies the measure of methylation in peripheral blood for myopia studies. Furthermore, our results indicate that dopamine can reduce both LINE-1 methylation and DNMT1 levels, which provides a novel mechanism for dopamine effect on myopia prevention. ACKNOWLEDGEMENTS Authors' contributions: Hsi E designed and conducted the study, analyzed the data and wrote the manuscript; Wang YS designed and conducted the study; Huang CW conducted the study; Yu ML designed the study and interpreted the data; Juo SH designed the study, analyzed and interpreted the data and wrote the manuscript; Liang CL designed the study, interpreted the data and wrote and approved the manuscript. 
